A regional health department is assessing the burden of a chronic autoimmune myopathy in a stable regional population of adults. Active epidemiological surveillance over the past decade demonstrates a steady incidence rate of new cases per persons per year. A breakthrough biologic therapy, introduced uniformly across the region several years ago, does not cure the condition but has successfully increased the average post-diagnosis survival time from years to years. Assuming steady-state epidemiological conditions have been reached, what is the expected total number of individuals currently living with this disease in the region?
- A
- B
- C
- Answer
- E
Answer
The expected total number of individuals currently living with the disease is .
In a steady-state population, the point prevalence (the total number of existing cases at a specific time) of a rare disease can be estimated using the relationship: . First, the absolute incidence for the entire region must be calculated. The incidence rate is given as cases per persons per year. For a regional population of , the absolute incidence is new cases per year. The introduction of the new biologic therapy successfully increased the average disease duration (post-diagnosis survival) from years to years. Using the updated steady-state duration, the expected prevalence is living prevalent cases.
Step-by-Step Solution
Key Concept
The relationship between point prevalence, absolute incidence, and disease duration in steady-state epidemiology ().
Estimated Time:1m 30s